Searched over 200M research papers
10 papers analyzed
These studies suggest that various stroke scales, including the NIHSS, mRS, BI, e-NIHSS, mNIHSS, SSS, and PROMIS GH, are valuable for assessing stroke severity, recovery, and outcomes, though they have limitations in long-term poststroke assessments and fully explaining functional health.
20 papers analyzed
The National Institutes of Health Stroke Scale (NIHSS) is a critical tool in modern neurology, widely used to assess the severity of stroke symptoms. It has become the gold standard for stroke severity rating, especially after its pivotal role in the NINDS r-tPA for Acute Stroke Trial. Over 500,000 healthcare professionals have been certified to administer the NIHSS, highlighting its extensive adoption in clinical practice.
The NIHSS is not only essential for clinical trials but also for regulatory compliance. The Joint Commission mandates an NIHSS score within 12 hours of admission for all stroke patients as part of its certification program for Primary Stroke Centers. This requirement underscores the scale's importance in ensuring standardized patient care and outcome reporting.
Despite its widespread use, the NIHSS has limitations, particularly in assessing posterior circulation strokes. To address this, the e-NIHSS was developed, which includes additional items to better evaluate posterior circulation stroke symptoms. Studies have shown that the e-NIHSS improves sensitivity and provides a more accurate assessment for these types of strokes.
Another modification, the mNIHSS, was created to enhance reliability and validity by removing items with poor reproducibility and collapsing redundant items. This modified version has shown improved reliability and is simpler to use in clinical research trials.
The NIHSS is often compared with other stroke scales such as the Scandinavian Stroke Scale (SSS). Research indicates that both scales are equally effective in predicting 3-month outcomes for stroke patients, suggesting that the SSS could be a viable alternative in clinical settings. Additionally, conversion equations have been developed to interconvert NIHSS and SSS scores, facilitating comparisons across different studies and clinical practices.
While the NIHSS is effective in acute stroke assessment, its validity in chronic stroke survivors is questionable. Studies have found no significant correlation between NIHSS scores and long-term health status measures such as the Stroke Impact Scale (SIS), indicating that the NIHSS may not be suitable for evaluating long-term outcomes.
No single scale can capture all dimensions of stroke recovery. The NIHSS is often used alongside other scales like the modified Rankin Scale (mRS), Barthel Index (BI), and Stroke Impact Scale (SIS) to provide a comprehensive assessment of stroke outcomes. Each scale has its strengths: the NIHSS is useful for early prognostication, the BI for planning rehabilitation, and the mRS and GOS for summarizing outcomes.
The NIHSS remains a cornerstone in stroke assessment, crucial for both clinical practice and research. However, its limitations necessitate the use of modified versions and complementary scales to ensure a holistic evaluation of stroke severity and recovery. Understanding these nuances can significantly enhance clinical decision-making and patient care in stroke management.
Most relevant research papers on this topic